Loading stock data…
Sanara MedTech Inc (SMTI)
$24.58+0.70 (+2.93%)
After Hours$25.00+0.42 (+1.71%)· Last close Jun 29
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sanara MedTech Inc. in the Healthcare sector is trading at $24.58 with a market capitalization of $205M. Wall Street consensus targets $34.33 (3 analysts), implying a +39.7% move over the next 12 months. The stock is currently 32% below its 52-week high of $35.95, remaining 6.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +39.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $27.80M↑ | $27.55M↑ | $26.33M↑ | $25.83M↑ | $23.43M |
| Gross Profit | $25.87M↑ | $25.67M↑ | $24.46M↑ | $23.89M↑ | $21.60M |
| Operating Income | $2.65M↓ | $2.89M↓ | $2.94M↑ | -$31,348↓ | $825,530 |
| Net Income | $458,957↑ | -$1.61M↑ | -$30.41M↓ | -$2.01M↑ | -$3.53M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolys...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$204.77M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-477.72%
Volume
Today's trading volume
52,582
Recent News
Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth
Sanara MedTech is back in focus as the consensus fair value estimate edges from US$34.00 to about US$34.33 per share, giving investors a refreshed reference point for the stock. That small move lines up with recent analyst commentary that leans constructive on the company’s role in surgical wound and soft tissue management and what that could mean for future execution and valuation work. In the sections ahead, you will see how this evolving narrative fits with updated growth and margin...
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript
Seth Yon: Thank you, operator, and welcome, everyone, to our first quarter 2026 earnings conference call. Demand for our products is strong, and we're particularly pleased with our first quarter results given that our first quarter is historically our seasonally slowest sales period of the year. Despite these challenges, we closed out the first quarter with the strongest sales month in company history in March, excluding October of 2024, which benefited from approximately $1.8 million of BIASURGE sales due to the industry disruption caused by Hurricane Helene.
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put
Sanara MedTech’s fair value target is held at US$34.00 per share, with no change from the previous US$34.00 estimate. Bullish and bearish analysts are reading that steady target very differently, with some seeing it as a sign of conviction in the updated model and others viewing it as heavily dependent on specific assumptions. As you read on, you will see what is driving these views and how to track the narrative as it develops. Analyst Price Targets don't always capture the full story. Head...
Sanara MedTech Inc. Q1 2026 Earnings Call Summary
Moby summary of Sanara MedTech Inc.'s Q1 2026 earnings call
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Sanara MedTech Inc (SMTI) reports a 19% revenue increase and strategic sales team expansion, despite facing operational challenges.